CoastWatcher
Moderator
Researchers hypothesized that TRT in older, hypogonadal men would improve cognition. 
In terms of Alzheimer-related symptoms, those in the group receiving testosterone all posted increased scores on Alzheimer's Disease Assessment Scale, and the Mini Mental Status Exam.
A small study, with a flawed testosterone protocol figuring prominently, nonetheless suggests that cognition can be positively influenced in Alzheimer's patients with the administration of testosterone.
Aging Male, 2003 March 6
https://www.ncbi.nlm.nih.gov/m/pubmed/12809076/?i=4&from=/28914204/related
	
		
			
		
		
	
				
			- Thirty six patients with a new diagnosis of Alzheimer's Disease were screened for hypogonadism.
 - Ten of these patients, 28% had total testosterone values of less than 240 ng/dl and were enrolled in a pilot study - five received testosterone and five received a placebo.
 - The protocol administered, 200mg of testosterone cypionate every two weeks, was a poor one (date of study was 2003).
 - Measurement of total testosterone, CBC, PSA, and lipids was done at the three, six, nine, and twelve month mark of treatment.
 - Total testosterone increased, a mean rise of 126.4 ng/dl, (meaning men were still hyogonadal in terms of symptoms).
 
In terms of Alzheimer-related symptoms, those in the group receiving testosterone all posted increased scores on Alzheimer's Disease Assessment Scale, and the Mini Mental Status Exam.
A small study, with a flawed testosterone protocol figuring prominently, nonetheless suggests that cognition can be positively influenced in Alzheimer's patients with the administration of testosterone.
Aging Male, 2003 March 6
https://www.ncbi.nlm.nih.gov/m/pubmed/12809076/?i=4&from=/28914204/related